-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly Assets, Current history and change rate from Q2 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Assets, Current for the quarter ending 30 Sep 2025 was $13,952,279, a 65.5% increase year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)